08 dec: USA: Antallet af nytilmeldte ledige skuffer
08 dec: Bavarian: Ledelse får tegningsoptioner og ansatte incitamentsprog..
08-12-2016 15:01:36

Bavarian Nordic Introduces New Incentive Programs for Executive Management and Employees

Relateret indhold
10 aug - 
Bavarian-partner tegner nye aktier til 405 kr. i udvide..
28 jul - 
Fredagens aktier: Lundbeck blev tynget af tysk skepsis
28 jul - 
Aktier/middag: Kun Novo Nordisk undgår depressiv stemni..
Relateret debat
16:20 - 
Risk / Reward analyse virker ikke i den her situation f..
15:09 - 
Lær nu at læse for pokker da. Jeg har ikke handlet hver..
14:34 - 
HAHAHA! Årets joke!

COPENHAGEN, Denmark, December 8, 2016 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the board has decided to issue warrants to executive management and certain employees in the Bavarian Nordic Group. The decision is made in accordance with the shareholder authorization for the board of directors adopted as Article 5b of the Articles of Association and the Company's guidelines regarding incentive programs.

The warrant program entails the issuance of 450,300 warrants in total which entitle the warrant holders to subscribe for up to 450,300 shares in total with a nominal value of DKK 10 each at an exercise price of DKK 260.2 per share. The warrants may be exercised wholly or partly during eight fixed subscription periods during 2020 and 2021.

The value of each warrant equals DKK 54.2 and is calculated on the Black-Scholes model with a risk-free interest rate of -0.48 per cent and on the historical volatility of the shares. The calculation is based on a share price of DKK 222.5.

Furthermore, the Company introduces a three year incentive program in January 2017 for certain employees in the Bavarian Nordic Group. The program is a cash bonus program based on the development in the Company's share price. The incentive program will not have a dilutive effect on the shareholders.

Each employee participating in the program is awarded so-called phantom shares every month of employment until 31 December 2019. The exercise price is DKK 260.2. The phantom shares may be exercised in January 2020, only if the Company's share price by then exceeds the exercise price by at least DKK 5. In that case, each phantom share will yield a cash bonus equivalent to DKK 1 per point the share price exceeds the exercise price.

Based on the current number of employees in the Group eligible for participating in the program, the program will comprise up to 58,032 phantom shares. Executive management and other employees receiving warrants will not participate in the program. The average value of each phantom share granted equals DKK 37.9 calculated on the basis of the Black-Scholes model with a risk-free interest rate of -0.48 per cent and on the historical volatility of the shares. The calculation is based on a share price of DKK 222.5.

About Bavarian Nordic

Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases, based on the Company's live virus vaccine platform. Through long-standing collaborations, including a collaboration with the U.S. government, Bavarian Nordic has developed a portfolio of vaccines for infectious diseases, including the non-replicating smallpox vaccine, IMVAMUNE®, which is stockpiled for emergency use by the United States and other governments. The vaccine is approved in the European Union (under the trade name IMVANEX®) and in Canada. Bavarian Nordic and its partner Janssen are developing an Ebola vaccine regimen, which has been fast-tracked, with the backing of worldwide health authorities, and a vaccine for the prevention and treatment of HPV. Additionally, in collaboration with the National Cancer Institute, Bavarian Nordic has developed a portfolio of active cancer immunotherapies, including PROSTVAC®, which is currently in Phase 3 clinical development for the treatment of advanced prostate cancer. The company has partnered with Bristol-Myers Squibb for the potential commercialization of PROSTVAC. For more information visit www.bavarian-nordic.com or follow us on Twitter @bavariannordic.

Forward-looking statements

This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law.

Contacts

Rolf Sass Sørensen

Vice President Investor Relations (EU)

Tel: +45 61 77 47 43

Seth Lewis

Vice President Investor Relations (US)

Tel: +1 978 341 5271

Company Announcement no. 31 / 2016

2016-31-en


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Bavarian Nordic A/S via Globenewswire

Vedhæftet fil: 774102.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
10 aug
BAVA
Så røg den tosse i filteret -.-
10
12 aug
BAVA
Tak til hr. Baronen for et seriøst indlæg. Jeg har Bavarian, men er nok endnu ikke klar til at begyn..
8
11 aug
BAVA
Jeg vil gerne tage Baronen i forsvar .... Jeg har fuldt lidt med på sidelinjen og kan konstatere at ..
8
10 aug
BAVA
Tier du så stille omkring Bavarian ? :)
8
15 aug
BAVA
Tror de fleste seriøse investorer herinde er ret ligeglade med jeres handler, men hvad med I skriver..
6
15 aug
BAVA
Ved lejlighed kunne du jo lige poste en af dine "store" transaktioner, bare antallet...Det virker så..
6
14 aug
BAVA
Speedfires indlæg længere nede, med linket til den bms ansatte er egentligt meget interresant. Han b..
6
09 aug
BAVA
Bavarian Nordic offentliggør tegningskurs og antal aktier, der skal udstedes til Johnson & Johnson I..
6
15 aug
BAVA
Umiddelbart positiv læsning for Bavarian, idet Bavarian's middel  har en anden tilgang til RSV. Men ..
5
12 aug
BAVA
Det bedste lige pt er tænke kort og tænke swing når det kommer til bava i disse usikre tider især fo..
5

Coloplast/CEO: Har underskrevet ny VA-kontrakt på trods af fejl

16-08-2017 14:33:48
En fejl i administrationen af kontrakten med det amerikanske veteranministerium, U.S Department of Veterans Affairs, har betydet, at det danske medicoselskab Coloplast vurderer, at det skal tilbagebetale 90 mio. kr. til ministeriet.Selskabets oplyste om engangsbeløbet i regnskabet for tredje kvartal af det forskudte regnskabsår 2016/2017, der blev fremlagt onsdag ved middagstid, og her fremgik det..

Aktier/middag: Mærsk og Carlsberg deles om top og bund i grønt C20

16-08-2017 11:33:01
Med plusser til størstedelen af de danske eliteaktier ligger C20 Cap-indekset onsdag middag i positivt terræn, og med til at trække op er Mærsk-aktierne efter koncernens regnskab. Omvendt bliver Carlsberg straffet for sit.Samlet går C20 Cap-indekset frem med 0,3 pct. til 1170,82, og dermed følger det danske eliteindeks trenden i resten af Europa, hvor de fleste aktieindeks ligeledes noterer stigni..

Aktier/tendens: Regnskaber i centrum for udvikling i C20 Cap

16-08-2017 08:36:09
Der er ikke meget påvirkning eller inspiration at hente fra udlandet for de danske investorer onsdag, og dagens udvikling i C20 Cap-indekset vil sandsynligvis blive bestemt af dagens regnskaber fra nogle af indekset tunge selskaber med A.P. Møller-Mærsk i spidsen.C20 Cap-indekset lukkede tirsdag med et fald på 0,1 pct. til 1167,07.De amerikanske aktier lukkede tirsdag med små udsving tæt på nulpun..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas/Sydbank: Sætter tungt aftryk på konkurrencepræget marked - NY
2
NNIT/CEO: Vi stopper ikke op og håber på Novo Nordisk
3
Spar Nord opjusterer og ændrer udbyttepolitik
4
Vestas bekræfter ordre på 424 MW i Mexico
5
Danske rederier har nået bunden - citat

Relaterede aktiekurser

Bavarian Nordic A/S 401,00 1,8% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
16. august 2017 17:13:42
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170808.1 - EUROWEB2 - 2017-08-16 17:13:42 - 2017-08-16 17:13:42 - 1 - Website: OKAY